“No matter the situation, people living with #schizophrenia deserve to be treated with compassion and understanding.” Matthew Shapiro, Senior Director, Government Affairs, NAMI NYS is an advocate for changing the discussions around schizophrenia. At Teva, we’re proud to share stories and spark discussions on #WorldSchizophreniaAwarenessDay and beyond. Learn more about why your words matter and join us in changing the stigma against #schizophrenia here: https://ow.ly/QwZO50ROVyt #Tevapharm
About us
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/
- Website
-
http://www.tevapharm.com
External link for Teva Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Tel-Aviv
- Type
- Public Company
- Specialties
- generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
Locations
Employees at Teva Pharmaceuticals
Updates
-
“I'm living with this condition nearly 40 years. It was debilitating my life. And now, with the new treatments, I can say that I have a better life.” Patricia Ripoll, migraine patient, Spain What happened when Patricia and other patients and caregivers met with Teva employees, and gave us a firsthand glimpse into the difference we make to their lives? Watch the emotional videos and find out: https://ow.ly/I6Lc50RSgE1 #Tevapharm #WeAreAllInForBetterHealth #PivottoGrowth #Patients
-
Meditation is not just a practice; it's a way of life. 🧘 On this World Meditation Day, Subhajit Goswami shares how meditation helped him in his #MentalHealth and #Wellbeing journey. Subhajit discovered meditation 15 years ago and has since practiced it every day. His daily practice has helped him achieve a state of contentment and inner peace while allowing him to manage his responses to stressful situations. His advice for beginners: "Effortless silent meditation can be practiced anywhere, at any time of the day. Just find a quiet place, sit comfortably and take a few deep breaths to gradually relax your body and get into the state of thoughtless awareness and pure joy." What led him to start practicing meditation, and what kept him dedicated to the practice for such a long time? Read his story here > https://ow.ly/sQPp50RH9V7 Do you practice meditation, or are you looking to start? Share with us in the comments below 👇 #WorldMeditationDay #MentalHealth #Meditation #Tevapharm
-
We are among the top 5 best mid-sized pharma employers in India! 🥳 Teva India is celebrating a big win at the AmbitionBox Employee Choice Awards (ABECA) 2024. Current and former employees of Teva India have voluntarily provided an impressive rating of 4.1 out of 5. What's our secret? It's not just the great work-life balance, supportive culture, or the fact that we celebrate our unique personalities – it's our amazing teams who shared their positive experiences and made this win possible. Ready to be part of something bigger? Explore our open positions in India: https://ow.ly/grXB50RMTJt #TevaIndia #ABECA2024 #Ambitionbox #EmployeeChoiceAwards #WeAreAllInForBetterHealth #Tevapharm
-
-
We all know that pharmacovigilance is about monitoring the safety of pharmaceutical products and preventing adverse events, hence guarding the patients using them, but what is eco-pharmacovigilance? 💡 Eco-pharmacovigilance is the science and activities concerning the detection, assessment, understanding, and prevention of adverse effects related to the presence of pharmaceuticals in the environment, which may affect humans and other animal species. Klaudija Marijanovic-Barac, from our #Pharmacovigilance and Patient Safety (PV) team, explains the importance of eco-pharmacovigilance for promoting better health for all >> https://ow.ly/eCyl50RtB1n #Tevapharm #EcoPharmacovigilance #PatientSafety #WeAreAllInForBetterHealth
-
Caregivers play a vital role in the treatment journey for patients, helping to manage a patient's overall well-being, both physically and mentally. Heather is a caregiver for her husband, Nathan, who is living with #Huntingtonsdisease (HD). She works every day to show up for those who need her. Watch her story to see how being a caregiver has impacted her life here: https://ow.ly/JBL450RGJqW #HDAwarenessMonth #InternationalHDAwarenessDay #HuntingtonDisease #TevaPharm #TevaCares
-
“My biggest passion is to help people. I've always looked at that as my inspiration, in my entire life I've been involved in helping others, especially through medicine.” - Giulia Ghibellini, Teva R&D, USA At Teva, we are all in for better health. We wake up every morning with a sense of purpose, knowing that nearly 200 million people in 58 countries benefit from one of Teva's quality medicines every day. When Giulia met Sherland, who is living with Tardive Dyskinesia, it helped her realize the profound impact of her work. Meet Giulia, Sherland and other employees, patients and caregivers, and learn how we are making a difference in the lives of the people we serve: https://ow.ly/TNX050Ryi3o #Tevapharm #WeAreAllInForBetterHealth #PivoTtoGrowth #Patients
-
-
#ICYMI: Yesterday we shared Teva's business results for Q1 2024. Hear more about Teva’s performance in Q1 2024, how we're all in for better health, and the next phases on our #PivotToGrowth journey. Access a replay of the Q1 2024 investor webcast here: https://ow.ly/6QSL50Rzg9X Forward-looking statements are subject to the cautionary note included in our Q1 2024 press release. #QuarterlyResults #Earnings #Tevapharm
-
-
Tune in live: Our Q1 2024 earnings call is starting in 30 minutes! Join CEO Richard Francis and the Teva leadership team live, and hear more about Teva's business performance, the progress on our #PivotToGrowth strategy, and plans ahead. Join here: https://ow.ly/BZQe50Rzhpv #QuarterlyResults #Earnings #Tevapharm
-
-
“In 2024, Teva is off to a good start, with global revenues of $3.8 billion showing growth of 5% in local currency terms compared to Q1 2023, fueled by robust growth in our generics business across all regions and continued growth of our innovative brands" - Richard Francis, Teva President and CEO We are pleased to share Teva’s Q1 2024 business results. View the full press release: https://ow.ly/6tnY50Rzjny Forward-looking statements are subject to the cautionary note included in our Q1 2024 press release. #QuarterlyResults #Earnings #Tevapharm #PivotToGrowth
Affiliated pages
Similar pages
Browse jobs
Stock
TEVA
NYSE
20 minutes delay
$16.60
-0.16 (-0.955%)
- Open
- 16.87
- Low
- 16.59
- High
- 16.9
Data from Refinitiv
See more info on